Centre Hospitalier de La Rochelle

La Rochelle 17000

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Critically Ill, Encephalopathy, Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma

Studies at this site

• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma — Stopped early
• Acute Encephalopathy in Critically Ill Patients With COVID-19 — Status unconfirmed